# Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma

> **NCT00060008** · NA · TERMINATED · sponsor: **Children's Hospital of Philadelphia** · enrollment: 18 (actual)

## Conditions studied

- Neurofibromatosis Type 1
- Precancerous Condition

## Interventions

- **RADIATION:** fludeoxyglucose F 18
- **RADIATION:** gadopentetate dimeglumine

## Key facts

- **NCT ID:** NCT00060008
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-04
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Study was closed early due to poor accrual.
- **Last updated:** 2014-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00060008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00060008, "Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00060008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*